Stock listing

OTC:SSKN STRATA Skin Sciences, Inc. Stock

Follow STRATA Skin Sciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:SSKN

$0.0001 USD 0.0000 (0.0%)

Close on Nov 5, 2026

Past year -75.0% · daily closes, Jul 13, 2026 – Nov 5, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDNov 5, 2026
Market cap
$589 USDAt the close on Nov 5, 2026 · price × 5.89M shares outstanding
Traded on an average day
$6 USDMedian day 0 shares · 32 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026
STRATA Skin Sciences, Inc. logo

Daily closes

Last 3 months, Aug 5, 2026 – Nov 5, 2026 · OTC:SSKN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0001-50.0%$0.0001$0.0001$0.00012,700
$0.0002+0.0001+100.0%$0.0002$0.0002$0.000210,309
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0001-50.0%$0.0001$0.0001$0.0001560
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002143,165
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00021,001
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002800
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002-0.0048-96.0%$0.0002$0.0002$0.0002182
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00501,009
$0.00500.00000.0%$0.0050$0.0050$0.0050619
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00502,500
$0.00500.00000.0%$0.0050$0.0050$0.0050981
$0.00500.00000.0%$0.0050$0.0050$0.0050157
$0.00500.00000.0%$0.0050$0.0050$0.0050653
$0.00500.00000.0%$0.0050$0.0050$0.00501,010
$0.00500.00000.0%$0.0050$0.0050$0.0050420
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.005011,606
$0.00500.00000.0%$0.0050$0.0050$0.00501,057
$0.00500.00000.0%$0.0050$0.0050$0.00508,345
$0.00500.00000.0%$0.0050$0.0050$0.005020,055
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.00500.00000.0%$0.0050$0.0050$0.00501,822
$0.00500.00000.0%$0.0050$0.0050$0.00505,720
$0.00500.00000.0%$0.0050$0.0050$0.00500
$0.0050-0.0005-9.1%$0.0002$0.0050$0.00022,333
$0.00550.00000.0%$0.0055$0.0055$0.00550
$0.00550.00000.0%$0.0055$0.0055$0.00550
$0.00550.00000.0%$0.0055$0.0055$0.00550

Splits

3 splits since 2014 · OTC:SSKN · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-5Consolidation
1-for-10Consolidation
Ticker
OTC:SSKN
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

STRATA Skin Sciences, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
Calls
16 calls with a replay · 16 with a transcript · latest Nov 13, 2025
Decks
25 decks · latest Dec 17, 2025

Valuation

EV/sales 0.3× against a median of 2.5×: 2nd lowest of 6 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · price Nov 5, 2026

Enterprise value
$8.36M USD
P/E
Loss
EV/sales
0.3×
EV/EBITDA
Negative EBITDA
Price/book
0.0×
Gross margin
58.3%
Operating margin
−19.0%
Net margin
−20.4%
Debt to equity
5.6×
Beta vs S&P 500
-0.94

Medical devices & supplies: the 10 companies nearest in size, of 449 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
STRATA Skin Sciences, Inc. · OTC:SSKNUS$589US$8.36Mn/a0.3×n/a0.0×−20.4%5.6×-0.94
Zero Candida Technologies Inc. · TSXV:ZCTUS$1.43M−US$59,297n/an/an/a2.2×n/a0.0×-0.17
Osteopore Ltd. · ASX:OSXUS$1.38MUS$596,079n/a0.3×n/an/a−121.8%n/an/a
SpectraCure AB · OMXSTO:SPECUS$978,306US$1.10Mn/a32.1×n/a0.1×n/a0.1×n/a
Odyssey Health Inc. · OTC:ODYYUS$716,421US$594,060n/an/an/an/an/an/a0.58
S2Medical AB Class B · OMXSTO:S2MUS$355,391US$300,229n/a0.2×n/a0.4×−62.1%0.0×n/a
Imaging Dynamics Company, Ltd. · TSXV:IDLUS$252,238US$243,907n/a8.8×n/an/an/an/a-0.28
Profusa, Inc. · NASDAQ:PFSAUS$195,866−US$8.20Mn/an/an/a0.0×n/a0.0×1.99
Sigyn Therapeutics, Inc. · OTC:SIGYUS$161,983US$3.93Mn/an/an/an/an/an/a1.70
Safe SA · EURONEXT:ALSAFUS$139,941US$14.53Mn/a2.5×n/an/a−75.9%n/an/a
Vicarious Surgical, Inc. · OTC:RBOTUS$19,432−US$9.77Mn/an/an/a0.0×n/a0.0×1.95
Median of the othersUS$303,815US$447,1452.5×0.1×−75.9%0.0×1.14

Forecasts

1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
10.80 USD · Analysts' mean
EPS, year to Dec 2025
-1.80 · 1 analyst

Team and board

Officers

OfficerRole
Dolev RafaeliVice-Chairman of the Board, President and Chief Executive Officer
Erica JordanPresident and Chief Executive Officer
Christopher LesovitzChief Financial Officer

Board

DirectorRole
Uri GeigerChairman of the Board
Dolev RafaeliVice-Chairman of the Board, President and Chief Executive Officer
Irit YanivDirector
Samuel RubinsteinDirector

Events

Calls

CallWhenStatus
STRATA Skin Sciences (OTC:SSKN) Q3 2025 Earnings CallThu, Nov 13, 2025 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q2 2025 Earnings CallWed, Aug 13, 2025 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q1 2025 Earnings CallWed, May 14, 2025 · 5:00 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q4 2024 Earnings CallThu, Mar 27, 2025 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q3 2024 Earnings CallWed, Nov 13, 2024 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q2 2024 Earnings CallWed, Aug 14, 2024 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q1 2024 Earnings CallWed, May 15, 2024 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q4 2023 Earnings CallWed, Mar 27, 2024 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q3 2023 Earnings CallTue, Nov 14, 2023 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q2 2023 Earnings CallWed, Aug 09, 2023 · 4:30 PM ETReplay
All 16 calls
CallWhenStatus
STRATA Skin Sciences (OTC:SSKN) Q4 2022 Earnings CallFri, Mar 31, 2023 · 8:30 AM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q3 2022 Earnings CallWed, Nov 09, 2022 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q2 2022 Earnings CallWed, Aug 10, 2022 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q1 2022 Earnings CallWed, May 11, 2022 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q4 2021 Earnings CallMon, Mar 21, 2022 · 4:30 PM ETReplay
STRATA Skin Sciences (OTC:SSKN) Q3 2021 Earnings CallWed, Nov 10, 2021 · 4:30 PM ETReplay

Results days

QuarterResults
Q3 2025Nov 13, 2025 · After close
Q2 2025Aug 13, 2025 · After close
Q1 2025May 14, 2025 · After close
Q4 2024Mar 25, 2025 · Before open
Q3 2024Nov 13, 2024 · After close
Q2 2024Aug 14, 2024 · After close
Q1 2024May 15, 2024 · After close
Q4 2023Mar 27, 2024 · After close
Q3 2023Nov 14, 2023 · After close
Q2 2023Aug 9, 2023 · After close
All 20 quarters
QuarterResults
Q1 2023May 15, 2023 · After close
Q4 2022Mar 31, 2023 · Before open
Q3 2022Nov 9, 2022 · After close
Q2 2022Aug 10, 2022 · After close
Q1 2022May 11, 2022 · After close
Q4 2021Mar 21, 2022 · After close
Q3 2021Nov 10, 2021 · After close
Q2 2021Aug 16, 2021 · After close
Q1 2021May 12, 2021 · After close
Quarter to Dec 31, 2020Mar 24, 2021 · After close

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (December 2025)Investor deck44 slidesDec 17, 2025
Investor Presentation (August 2025)Investor deck45 slidesAug 18, 2025
Investor Presentation (December 2024)Investor deck37 slidesDec 11, 2024
Q3 2023 Earnings PresentationEarnings12 slidesNov 15, 2023
Investor Presentation (January 2023)Investor deck22 slidesJan 9, 2023
Investor Presentation (August 2022)Investor deck28 slidesAug 29, 2022
Investor Presentation (May 2022)Investor deck27 slidesMay 19, 2022
Investor Presentation (April 2022)Investor deck28 slidesApr 1, 2022
Investor Presentation (March 2022)Investor deck30 slidesMar 14, 2022
Investor Presentation (January 2022)Investor deck30 slidesJan 10, 2022
All 25 decks
DeckKindSlidesDate
Investor Presentation (August 2021)Investor deck23 slidesAug 25, 2021
Investor Presentation (November 2020)Investor deck34 slidesNov 12, 2020
Investor Presentation (January 2020)Investor deck33 slidesJan 13, 2020
Investor Presentation (November 2019)Investor deck33 slidesNov 21, 2019
Investor Presentation (August 2019)Investor deck26 slidesAug 7, 2019
Investor Presentation (June 2019)Investor deck28 slidesJun 10, 2019
Investor Presentation (April 2019)Investor deck35 slidesApr 2, 2019
Investor Presentation (February 2019)Investor deck35 slidesFeb 26, 2019
Investor Presentation (January 2019)Investor deck27 slidesJan 7, 2019
Investor Presentation (June 2018)Investor deck23 slidesJun 20, 2018
Investor Presentation (May 2018)Investor deck33 slidesMay 29, 2018
Investor Presentation (January 2018)Investor deck16 slidesJan 9, 2018
Investor Presentation (September 2017)Investor deck15 slidesSep 15, 2017
Mela Sciences — Needham Growth Conference 2013Conference35 slidesJan 17, 2013
Electro Optical Sciences — IPO Roadshow (July 2008)IPO roadshow42 slidesJul 28, 2008

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue30.7M33.6M33.4M36.2M30.0M23.1M31.6M29.9M31.4M31.8M
Cost of revenue12.8M14.5M14.9M14.4M10.1M8.96M11.3M12.7M13.5M12.6M
Gross profit17.9M19.1M18.5M21.8M19.9M14.1M20.3M17.1M18.0M19.1M
Research and development421.0K883.0K1.32M1.03M1.43M1.27M1.00M1.06M1.71M1.93M
Selling, general and administrative10.2M11.3M10.5M10.1M9.71M7.90M10.3M8.79M7.40M7.64M
Operating income-5.83M-9.26M-8.60M-4.65M-4.40M-4.08M-3.01M-3.35M-2.41M-3.60M
Depreciation and amortization4.47M5.31M5.90M5.69M4.09M3.91M4.82M5.40M6.34M6.37M
EBITDA-1.37M-3.95M-2.70M1.04M-316.0K-165.0K1.81M2.04M3.93M2.77M
Interest expense1.96M2.11M1.64M926.0K314.0K211.0K515.0K03.20M4.90M
Income before tax-6.25M-10.3M-10.9M-5.49M-2.67M-4.14M-3.94M-4.30M-18.7M-3.08M
Income tax12.0K-170.0K-92.0K63.0K34.0K275.0K-149.0K-264.0K129.0K255.0K
Net income-6.26M-10.1M-10.8M-5.55M-2.71M-4.41M-3.79M-4.03M-21.5M-3.33M
Earnings per share, basic-0.13-0.26-0.31-0.16-0.08-0.13-0.12-0.13-3.26-1.44

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents7.91M7.26M6.78M5.43M12.6M10.6M8.13M16.5M4.07M3.93M
Short-term investments00
Receivables4.12M5.25M4.44M4.47M3.43M2.94M4.39M3.39M3.14M3.39M
Inventory2.81M2.25M2.67M5.55M3.49M3.44M3.03M2.79M3.01M2.82M
Current assets15.6M16.6M15.5M17.5M20.0M24.8M23.6M23.2M10.8M10.8M
Property, plant and equipment7.52M6.52M5.37M5.30M7.70M10.2M
Goodwill1.43M2.66M6.52M8.80M8.80M8.80M8.80M8.80M8.80M8.80M
Total assets30.5M36.2M42.0M52.3M46.6M46.8M47.3M47.5M38.6M43.2M
Accounts payable2.76M2.43M3.34M3.42M2.82M2.76M1.88M6.26M2.28M1.85M
Current liabilities26.7M14.6M12.2M13.4M12.8M18.8M17.4M8.62M7.67M6.13M
Long-term debt15.2M15.0M7.48M7.32M1.05M7.14M7.85M21.8M
Total debt16.3M16.4M15.6M8.44M8.03M10.9M8.67M7.40M10.6M23.8M
Total liabilities27.6M31.2M29.3M30.4M21.2M20.9M18.7M16.3M16.4M28.5M
Shareholders' equity2.91M4.97M12.7M21.8M25.4M25.9M28.7M31.2M22.2M14.7M
Shares outstanding46.5M38.1M34.9M34.7M34.1M33.6M32.0M29.9M6.60M2.32M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-2.79M188.0K-519.0K-1.11M1.51M2.10M2.23M2.90M4.14M322.0K
Capital spending-1.47M-1.64M-5.02M-3.55M-3.65M-2.16M-2.79M-1.76M-1.74M-1.01M
Free cash flow-4.26M-1.45M-5.54M-4.66M-2.15M-63.0K-562.0K1.13M2.40M-686.0K
Cash from investing-1.47M-1.64M-5.02M-4.18M-7.13M-2.16M-2.79M-1.78M-2.19M-868.0K
Cash from financing3.58M1.93M6.86M-500.0K92.0K2.55M-296.0K11.3M-1.80M1.17M
Dividends paid00
Share buybacks18.0K14.7M06.00B
Change in cash-683.0K477.0K1.32M-5.79M-5.53M2.48M-858.0K12.4M141.0K625.0K

Open Financials

Cap table

Built by 6ix from STRATA Skin Sciences, Inc.’s releases

Common shares
5,888,199
Fully diluted
5,888,199

Fully diluted

LineShares
Common shares5,888,199

Share count over time

CountShares
Nov 22, 20265,888,199

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Gill
Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past)
Director · May 30, 2018 – Nov 22, 2019 · Past
Nachum Shamir
Other companies: MediWound Ltd. (Chairman · Since at least Mar 18, 2026); Stereotaxis, Inc. (Director · Since at least Jul 18, 2024); IsoPlexis Corp (Director · Aug 22, 2022 – Mar 21, 2023 · Past); Cactus Acquisition Corp. 1 Limited (Director · Oct 28, 2021 – Oct 28, 2021 · Past); Cogentix Medical Inc (Director · Nov 3, 2016 – Apr 23, 2018 · Past)
Director · May 30, 2018 – Jul 5, 2023 · Past
Samuel E Navarro
Other companies: Streamex Corp. (Director · Jun 21, 2019 – Dec 28, 2021 · Past); Derma Sciences Inc (Director · May 28, 2015 – Feb 24, 2017 · Past); Dextera Surgical Inc (Director · Dec 11, 2014 – Nov 22, 2016 · Past); MELA Sciences Inc (Director · Mar 11, 2014 – Dec 1, 2015 · Past)
Director · Dec 6, 2016 – Oct 9, 2020 · Past
Mathew C Hill
Other companies: Apyx Medical Corporation (Chief Financial Officer · Since at least Dec 4, 2023); PDS Biotechnology Corporation (Chief Financial Officer · Oct 18, 2021 – Jan 5, 2023 · Past); Ep Medsystems Inc (Chief Financial Officer · Dec 12, 2006 – Dec 12, 2006 · Past)
Chief Financial Officer · May 15, 2018 – Nov 13, 2020 · Past
LuAnn Via
Other companies: MELA Sciences Inc (Director · Apr 26, 2012 – Dec 1, 2015 · Past); Collective Brands Inc (President and CEO - Payless · Mar 10, 2009 – Oct 9, 2012 · Past)
Director · Dec 6, 2016 – Jul 20, 2021 · Past
Uri Geiger
Other companies: NeuroPace, Inc. (Director · Since at least Jan 5, 2023); Minerva Surgical, Inc. (Director · Feb 9, 2023 – Feb 9, 2023 · Past)
Director · Jul 15, 2024 – Jul 15, 2024 · Past
Kathryn B Swintek
Other companies: MELA Sciences Inc (Director · Apr 25, 2013 – Dec 1, 2015 · Past)
Director · Dec 6, 2016 – Dec 1, 2017 · Past
Richard Rox Anderson
Other companies: MELA Sciences Inc (Director · Sep 30, 2015 – Dec 1, 2015 · Past)
Director · Dec 6, 2016 – Dec 6, 2016 · Past
Samuel Rubinstein
Other companies: MediWound Ltd. (Director · Since at least Mar 18, 2026)
Director · Since at least May 30, 2018
Dolev RafaeliChief Executive Officer, Director · Apr 10, 2018 – May 13, 2025 · Past
All 14 people
PersonSeat
Erica JordanPresident and Chief Executive Officer · Since at least Nov 5, 2026
Irit YanivDirector · Since at least Oct 26, 2023
Robert Joseph MocciaChief Executive Officer, Director · Mar 1, 2021 – Aug 10, 2023 · Past
Shmuel GovChief Operating Officer · Apr 1, 2022 – May 13, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about STRATA Skin Sciences, Inc.